Takeda Pharmaceutical

TKPHF · TOKYO

$39.93+$0.93 (+2.38%)TodayMarket closed ·
Prev close $39.00

About TKPHF

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.

Employees
47,455
Headquarters
Chuo-Ku, Tokyo-To
Listed
May 16, 1949
Sector
Health Care
Industry
Pharmaceuticals
Website
takeda.com

Leadership

Takeda Pharmaceutical executives
NameTitleSince
Masami Iijima——
Christophe Weber—2014
Costa Saroukos—2019
Andrew Plump—2015
Olivier Bohuon——
Jean-Luc Butel——
Ian Clark—2019
Yoshiaki Fujimori——
Steven Gillis——
Koji Hatsukawa——
Emiko Higashi——
John Maraganore——
Michel Orsinger——
Kimberly Reed——
Miki Tsusaka——
Tokumasa Takeda—2016

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.